rotation.to
Following this device: dark.
Free account
rotation.to
Sign in / Request free access
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

Marc J. Yoskowitz

Director

Company insider

Files Form 4 as: Director, Keenova Therapeutics; Director, Mereo BioPharma Group; SVP, Strategy & Corporate Dev, Hospira.

Every Form 4 they filed

In numbers

Trades disclosed
36
Buys
0
Sells
1
Bought
$0
Sold
$691K
Companies
3
Companies where not an officer
2
First trade
30 Sep 2014
Last trade
15 Jul 2026
Last filed
17 Jul 2026

Companies traded

Where they are an officer
HospiraOfficer · last 3 Sep 20150 buys · 1 sell
Everywhere else they filed: board seats, 10% stakes, other companies
Keenova TherapeuticsDirector · last 15 Jul 20260 buys · 0 sells
MREO Mereo BioPharma GroupDirector · Biotechnology · last 26 Feb 20260 buys · 0 sells

Activity over time

1 Nov 2024 – 1 Oct 2026
101Nov 24May 25Nov 25Apr 26Oct 26

Buys above the line, sells below, each month.

Every trade

TradedCompanyWhatAmount
15 Jul 2026filed 17 Jul 2026Keenova Therapeuticsoption or derivativeSEC FORM 4 Code A—4,406 at $0.00filing
15 Jul 2026filed 17 Jul 2026Keenova Therapeuticsoption or derivativeSEC FORM 4 Code A—4,406 at $0.00filing
2 Jun 2026filed 4 Jun 2026Keenova TherapeuticsSEC FORM 4 Code M—3,579filing
2 Jun 2026filed 4 Jun 2026Keenova TherapeuticsSEC FORM 4 Code F—825filing
2 Jun 2026filed 4 Jun 2026Keenova Therapeuticsoption or derivativeSEC FORM 4 Code D—2,930filing
2 Jun 2026filed 4 Jun 2026Keenova Therapeuticsoption or derivativeSEC FORM 4 Code D—2,930filing
2 Jun 2026filed 4 Jun 2026Keenova Therapeuticsoption or derivativeSEC FORM 4 Code M—3,579 at $0.00filing
2 Jun 2026filed 4 Jun 2026Keenova Therapeuticsoption or derivativeSEC FORM 4 Code M—3,579 at $0.00filing
2 Jun 2026filed 4 Jun 2026Keenova TherapeuticsSEC FORM 4 Code M—3,579filing
2 Jun 2026filed 4 Jun 2026Keenova TherapeuticsSEC FORM 4 Code F—825filing
26 Feb 2026filed 27 Feb 2026MREO Mereo BioPharma Groupoption or derivative · BiotechnologySEC FORM 4 Code A—66,000 at $0.00filing
26 Feb 2026filed 27 Feb 2026MREO Mereo BioPharma Groupoption or derivative · BiotechnologySEC FORM 4 Code A—96,163filing
26 Feb 2026filed 27 Feb 2026MREO Mereo BioPharma Groupoption or derivative · BiotechnologySEC FORM 4 Code A—66,000 at $0.00filing
26 Feb 2026filed 27 Feb 2026MREO Mereo BioPharma Groupoption or derivative · BiotechnologySEC FORM 4 Code A—96,163filing
23 Feb 2026filed 25 Feb 2026Keenova Therapeuticsoption or derivativeSEC FORM 4 Code A—5,312 at $0.00filing
23 Feb 2026filed 25 Feb 2026Keenova Therapeuticsoption or derivativeSEC FORM 4 Code A—5,312 at $0.00filing
20 Oct 2025filed 20 Oct 2025Mallinckrodtoption or derivativeSEC FORM 4 Code A—1,354 at $0.00filing
14 Aug 2025filed 18 Aug 2025Mallinckrodtoption or derivativeSEC FORM 4 Code A—4,062 at $0.00filing
5 Feb 2025filed 6 Feb 2025MREO Mereo BioPharma Groupoption or derivative · BiotechnologySEC FORM 4 Code A—55,000 at $0.00filing
5 Feb 2025filed 6 Feb 2025MREO Mereo BioPharma Groupoption or derivative · BiotechnologySEC FORM 4 Code A—13,719filing

News

No headline names them, or the companies they trade most, lately.

Sectors

Not placed1

Buys in green, sells in red, by the company’s sector.

Related people

Nobody else traded the same names lately.